Expanding the genotype-phenotype spectrum of ISCA2-related multiple mitochondrial dysfunction syndrome-cavitating

Tamar Gur Hartman1,2, Keren Yosovich3, Hila Gur Michaeli3

  • 1Pediatric Neurology Unit, Wolfson Medical Center, Holon, Israel.

Neurogenetics
|May 20, 2020
PubMed

Insights

Iron-sulfur cluster assembly 2 (ISCA2) gene variants cause mitochondrial leukoencephalopathy. A milder phenotype presents with unique MRI findings and a longer lifespan, expanding the known clinical spectrum.

Area of Science:

  • Genetics
  • Neuroscience
  • Mitochondrial Biology

Background:

  • Iron-sulfur cluster assembly 2 (ISCA2)-related multiple mitochondrial dysfunction syndrome 4 (MMDS4) is a severe, fatal mitochondrial leukoencephalopathy.
  • Typically presents in infancy with rapid neurodevelopmental decline, leading to a vegetative state and early death, characterized by demyelinating leukodystrophy on MRI.

Observation:

  • A unique case of an 11-year-old boy with a milder ISCA2-related disorder is presented.
  • Manifestations included normal early development followed by acute neurological deterioration, resulting in stable spastic quadriparesis, optic atrophy, and mild cognitive impairment.
  • Initial MRI showed diffuse demyelinating leukodystrophy, with subsequent scans revealing white matter rarefaction and cysts.

Findings:

  • The patient carries two novel bi-allelic variants in the ISCA2 gene: p.Ala2Asp and p.Pro138Arg.
  • These variants were inherited from heterozygous carrier parents.

Implications:

  • This case expands the clinical spectrum of ISCA2-related disorders, demonstrating a milder phenotype with prolonged survival and better psychomotor function.
  • The findings highlight cavitating leukodystrophy as a potential MRI characteristic in milder forms.
  • Further research into genotype-phenotype correlations may explain the diverse clinical presentations of ISCA2-related disorders.